http://www.peregrineinc.com/ () —
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, today announced it will present at the Rodman & Renshaw 12th Annual Healthcare Conference on Monday, September 13, 2010 at 4:30 pm EDT.
A live webcast of the presentation will be available in the Investors section of Peregrine's website at http://www.peregrineinc.com (http://www.peregrineinc.com) . A replay will be available on the Peregrine website for 30 days.
For more information about this conference, please visit:http://www.rodmanandrenshaw.com/conferences?id51 (http://www.rodmanandrenshaw.com/conferences?id51)
About Peregrine PharmaceuticalsPeregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara@. Peregrine also has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com (http://www.avidbio.com) ), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com (http://www.peregrineinc.com) .